Clinical Trials Directory

Trials / Completed

CompletedNCT01665157

Efficacy and Acceptability of Low-Residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

A Randomized, Single-blinded, Comparative Study to Evaluate the Efficacy and the Acceptability of Low-residue Diet Package (Enimaclin®) as Diet Control Before Colonoscopy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
National Taiwan University Hospital · Academic / Other
Sex
All
Age
20 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Detailed description

In this study, we investigate a randomized, single-blinded, comparative study to evaluate the efficacy and the acceptability of low-residue diet package (Enimaclin®) as diet control before colonoscopy.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTEnimaclin®Enimaclin Colomil ® (Glico Co., Japan Osaka),a low-residue diet package for each meal. The duration of study is one day before colonoscopy.
OTHERSelf-controlled dietSelf-controlled low residue diet.
DRUG2L PEG-ELSNormal volume of PEG-ELS
DRUGlow volume 1.5L PEG-ELSLow volume PEG-ELS

Timeline

Start date
2011-11-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2012-08-15
Last updated
2014-04-02
Results posted
2014-02-06

Locations

4 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01665157. Inclusion in this directory is not an endorsement.